UNSPSC 51422118: Fluocortolone caproate

This classification denotes a therapeutic glucocorticoid C28H39FO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 90893P8662, chemically known as hexanoic acid, 21-ester with 6.alpha.-fluoro-11.beta.,21-dihydroxy-16.alpha.-methylpregna-1,4-diene-3,20-dione, but more generally known as fluocortolone caproate, which bears US NIH Compound Identifier 20054915. European Medicines Agency schedules Fluocortolone caproate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13901MIG.

Most nations, for tariff and trade purposes, schedule fluocortolone caproate under HS 29372200 and SITC 54153. As of Q4 2014, FLUOCORTOLONE CAPROATE remains US FDA's Preferred Term for this commodity. SMILES: CCCCCC(=O)OCC(=O)[C@H]1[C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2C[C@@H](C4=CC(=O)C=C[C@]34C)F)O)C)C.

UNSPSC 51422118 Fluocortolone caproate is a Commodity code that nominally covers a specific topical corticosteroid pharmaceutical ingredient, but the recent state and local procurement activity under this code does not align with that scope. The single recent opportunity on record — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023 — solicits Naloxone and Safe Drug Deactivation Systems for community health initiatives, a product category unrelated to fluocortolone caproate. The county is seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building. Bidders must include all shipping and delivery costs in their proposals, comply with drug-free workplace certification and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract term is two years with an option for one-year renewal, and the procurement is potentially FEMA-funded, introducing federal compliance obligations including adherence to the Clean Air Act and Federal Water Pollution Control Act.

The code shows minimal recent state and local activity aligned with its nominal pharmaceutical scope. Beyond the single Seminole County opportunity, no other state or local solicitations under UNSPSC 51422118 appear in the recent-opportunities block. The mismatch between the code's pharmaceutical classification and the naloxone procurement suggests either a tagging error or limited use of this code for its intended commodity. Business development professionals evaluating pursuit under fluocortolone caproate should note that current state and local demand signals under this code do not reflect the product category the code nominally describes.